New York, New York (PRWEB) July 31, 2013
Bernstein Liebhard LLP continues to monitor developments in the federal multidistrict litigation underway in Indiana federal court for Biomet hip replacement lawsuit (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) claims involving the Biomet M2a Magnum hip device. According to court records, the litigation’s most recent telephonic Status Conference was held on July 29, 2013, at which time matters involving the status of discovery, dispositive motions deadlines and the selection of bellwether cases were discussed. According to a Memorandum issued by the Court on July 30th, the next Case Management Conference for the proceeding will be convened on September 23, 2013 at 9:30 a.m. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation, MDL No. 2391, N.D. Ind.).
“We are actively filing Biomet hip lawsuits in this litigation, and continue to hear from recipients of the M2a Magnum hip who have allegedly suffered serious injuries due to its metal-on-metal design. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential case evaluations to individuals who may have been injured by this Biomet hip replacement device.
Biomet Hip Lawsuit
Court documents indicate that more than 500 Biomet hip replacement lawsuits are now pending in the Northern District of Indiana. All of the complaints allege that recipients of the Biomet M2a Magnum hip suffered serious complications, including metallosis, chronic pain, and premature failure of the hip, due to shedding of toxic metal debris caused by wear of its metal components.
Metal-on-metal hips, like the Biomet hip replacement named in these claims, are the subject of U.S. Food & Drug Administration (FDA) safety review, amid concerns that recipients of such devices may be at increased risk for bone and tissue damage, pain, implant loosening, and premature device failure. On January 17, 2013, the FDA advised patients with metal-on-metal hip implants to undergo metal ion screening if they were experiencing symptoms of hip failure. The agency also announced that it had proposed new regulations that, if adopted, would subject all-metal implants to greater regulatory scrutiny.
Victims of alleged Biomet hip replacement complications may be entitled to compensation for their medical expenses, lost wages and pain and suffering. Read More about fling a Biomet hip lawsuit at Bernstein Liebhard LLP’s website. For additional information and a free case review, please call one our attorneys today at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
Read the full story at http://www.prweb.com/releases/biomet-hip-lawsuit/biomet-hip-replacement/prweb10985019.htm.
Copyright©2012 Vocus, Inc.
All rights reserved